Pharma Mar, S.A.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0RC6.IL | RCUS | SNDX | BHVN | 688382.SS | IDYA | |
|---|---|---|---|---|---|---|
| Market cap | 1.22B | 2.43B | 940.80M | 2.30B | 8.38B | 3.12B |
| P/E (TTM) | 60.6 | — | — | — | — | — |
| Forward P/E | — | -6.2 | -14.4 | -8.2 | -43.8 | -7.9 |
| Price/book | 5.7 | 3.8 | -54.7 | -23.4 | 6.6 | 2.9 |
| Dividend yield | 2.09% | — | — | — | — | — |
| 1-year change | −8.11% | −1.28% | −28.86% | +78.66% | −48.70% | +8.41% |
| Today | +1.51% | +2.12% | −26.87% | −2.37% | +4.33% | +3.29% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 0RC6.IL news ›Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year Low – Here’s What Happened
Posted by Danessa Lincoln on Oct 31st, 2026 Shares of Pharma Mar (OTCMKTS:PHMMF – Get Free Report) reached a new 52-week low during trading on Thursday. The stock traded as low as $77.09 and last traded at $77.09, with a volume of 360…
Pharma Mar (PHMMF) Projected to Release Earnings on Thursday
Posted by Defense World Staff on Oct 28th, 2026 Pharma Mar (OTCMKTS:PHMMF – Get Free Report) will likely be posting its resultson Thursday, October 29th. Analysts expect Pharma Mar to post earnings of $0.0038 per share and revenue of…
Pharma Mar
S.A. is a Spain-based biopharmaceutical company focused on discovering, developing and commercializing medicines derived from marine organisms. The company’s primary area of activity is oncology, supported by a library of marine compounds…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net1
- marketbeat.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.